There were no statistically significant differences in median TF PCA levels between AML patients (n = 69) and patients with either MDS (n = 7) or ALL (n = 5), albeit none of the latter patients had a PBMC-associated TF PCA level of >1,500 AU/106 cells (Fig. 1a). This evidence concerns the gene TF and acute myeloid leukemia.